1-17 of 17
David T. Teachey
Close
Sort by
Articles

A New Target for B-ALL CAR-T

Caroline Diorio, MD, David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2020) 18 (1)
Published: 2020
Articles

It’s Not a No Brainer: Improved Outcome in Children With Ph+ B-ALL When Treated With a CNS-Penetrating TKI

Susan McClory, MD, PhD, David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2020) 17 (6)
Published: 2020
Articles

Three Is Not Better Than One: Intrathecal Triple Therapy Is Not Superior to Intrathecal Methotrexate in Children With HR B-ALL

Lisa M. Niswander, MD, PhD, David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2020) 17 (5)
Published: 2020
Articles

Convalescent Plasma for COVID-19: An Old Therapy for a Novel Pathogen

Caroline Diorio, MD, FRCPC, FAAP, David T. Teachey, MD, Hamid Bassiri, MD, PhD
Journal: The Hematologist
The Hematologist (2020) 17 (4)
https://doi.org/10.1182/hem.V17.4.10407
Published: 2020
Articles

Bringing Immunotherapy to the Front Line in Childhood Leukemia

David T. Teachey, MD, Stephanie J. Si, MD
Journal: The Hematologist
The Hematologist (2020) 17 (3)
https://doi.org/10.1182/hem.V17.3.10331
Published: 2020
Articles

Outcomes for Children With SR-ALL: More Is Not Always Better

David T. Teachey, MD, Caroline Diorio, MD, FRCPC, FAAP
Journal: The Hematologist
The Hematologist (2020) 17 (2)
https://doi.org/10.1182/hem.V17.2.10282
Published: 2020
Articles

Germline Predisposition to Childhood Leukemia: T-ALL Risk Variants Uncovered in GWAS

David T. Teachey, MD, Suzanne P. MacFarland, MD
Journal: The Hematologist
The Hematologist (2020) 17 (1)
https://doi.org/10.1182/hem.V17.1.10159
Published: 2020
Articles

A Novel Immunotherapy for T-ALL

David T. Teachey, MD, Caroline Diorio, MD, FRCPC, FAAP
Journal: The Hematologist
The Hematologist (2019) 16 (6)
https://doi.org/10.1182/hem.V16.6.9932
Published: 2019
Articles

Venetoclax for Hypodiploid ALL: Novel Therapy for Bad Biology

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2019) 16 (5)
https://doi.org/10.1182/hem.V16.5.9816
Published: 2019
Articles

Popping the Bubble: Promising Results From a Phase I-II Lentiviral Gene Therapy Trial for X-SCID

David T. Teachey, MD, Danielle E. Arnold, MD
Journal: The Hematologist
The Hematologist (2019) 16 (4)
https://doi.org/10.1182/hem.V16.4.9661
Published: 2019
Articles

Hematopoietic Stem Cell Transplantation: Not Always a Panacea for Leukemia Patients With Unfavorable Outcome

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2019) 16 (3)
https://doi.org/10.1182/hem.V16.3.9580
Published: 2019
Articles

JAKing Up Targeted Therapy for Ph-like Acute Lymphoblastic Leukemia

Yang-Yang Ding, MD, David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2019) 16 (2)
https://doi.org/10.1182/hem.V16.2.9412
Published: 2019
Articles

From Aminopterin to Tisagenlecleucel: Childhood Acute Lymphoblastic Leukemia at the Forefront of Cancer Breakthroughs

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9312
Published: 2018
Articles

A New Standard of Care for Children and Young Adults With T-cell Acute Lymphoblastic Leukemia

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9033
Published: 2018
Articles

Remission: More Than Meets the Eye

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2018) 15 (4)
https://doi.org/10.1182/hem.V15.4.8734
Published: 2018
Articles

The Importance of Genomic Testing in Children With Complex Autoimmune Cytopenias: Precision Medicine Is Not Just for Cancer

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8476
Published: 2018
Articles

Novel Insights From Comprehensive Genomic Profiling of T Cell Acute Lymphoblastic Leukemia

David T. Teachey, MD
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8270
Published: 2018